product summary
company name :
Cell Marque
product type :
antibody
product name :
Anti-Ki-67 Monoclonal Antibody, Unconjugated, Clone SP6
catalog :
275R-18
clonality :
monoclonal
conjugate :
nonconjugated
clone name :
SP6
reactivity :
human, mouse, rat
application :
immunohistochemistry, immunohistochemistry - paraffin section
more info or order :
citations: 5
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - paraffin section; rat; 1:100; loading ...; fig 5a
Connolly N, Stokum J, Schneider C, Ozawa T, Xu S, Galisteo R, et al. Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer. PLoS ONE. 2017;12:e0174557 pubmed publisher
  • immunohistochemistry; mouse; 1:500; fig s3
Yang H, Vainshtein A, Maik Rachline G, Peles E. G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination. Nat Commun. 2016;7:10884 pubmed publisher
  • immunohistochemistry - paraffin section; human; 1:50; tbl 2
Kong G, Hofman M, Murray W, Wilson S, Wood P, Downie P, et al. Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma. J Pediatr Hematol Oncol. 2016;38:87-96 pubmed publisher
  • immunohistochemistry; mouse; fig 5
Haupt S, Buckley D, Pang J, Panimaya J, Paul P, Gamell C, et al. Targeting Mdmx to treat breast cancers with wild-type p53. Cell Death Dis. 2015;6:e1821 pubmed publisher
  • immunohistochemistry - paraffin section; human; fig 2
Cheng Y, Holloway M, Nguyen K, McCauley D, Landesman Y, Kauffman M, et al. XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer. Mol Cancer Ther. 2014;13:675-86 pubmed publisher
company information
Cell Marque
6600 Sierra College Blvd. Rocklin, California 95677
service@cellmarque.com
http://www.cellmarque.com
headquarters: United States